AKT1 and ovarian cancer: EVO could significantly inhibit the cell growth and enhance apoptosis via inducing G2/M cell cycle arrest and targeting the apoptotic, MAPK, and PI3K/Akt pathways in human ovarian cancer HO-8910PM cells (Wei et al., 2016).